Yahoo India Web Search

Search results

    • Roche to fast-track weight loss drugs to compete with rivals

      CNBC Awaaz· 10 minutes ago

      Roche is among a growing number of would-be rivals to Novo and Eli Lilly, whose weight-loss injections have been in feverish demand, with experts boosting their sales forecasts for such treatments to as much as $150 billion by the early 2030s.